Harvard Psychopharmacology 2025 A Master Class

Neurobiology, Brain Function and Clinical Relevance

• Updated neurobiology for the practicing clinician
• Understanding brain function and its clinical relevance
• Neurotransmitter circuits, transmitters, receptors, and synaptic function
• Gene transcription and interaction between genes and the environment
• Clinical relevance of brain circuitry for psychiatric treatment
• New neurobiological research findings that influence clinical practice

Treatment-Resistant Depression and Mood Disorders

• Treatment-resistant depression update
• New antidepressants and modern pharmacologic strategies
• Polypharmacy and augmentation strategies
• Ketamine, psychedelics, ECT, and TMS in treatment-resistant depression
• Treatment of bipolar disorders and clinical directions
• Revival of lithium and updated mood stabilizer considerations
• Bipolar depression and long-term maintenance strategies

Schizophrenia, Psychosis and Difficult-to-Treat Patients

• Treatment for schizophrenia: prodrome, first episode, relapse, and new treatment possibilities
• Pharmacologic treatment of schizophrenia across illness stages
• Long-term maintenance treatment strategies
• Treatment-resistant psychotic disorders
• New antipsychotic medications and treatment augmentation
• Therapeutic approaches to the difficult psychiatric patient
• Importance of the therapeutic alliance when prescribing psychotropic medications

Anxiety Spectrum Disorders, PTSD and Trauma-Related Disorders

• Treatment of anxiety-spectrum disorders
• Panic disorder, social anxiety disorder, and generalized anxiety disorder
• New data on the risks and benefits of benzodiazepines
• Psychopharmacology of trauma-related disorders
• Etiology and standard pharmacological treatment of PTSD
• Clinical use of psychedelics and ketamine for PTSD
• Evidence-informed treatment planning for trauma-related psychiatric illness

Women’s Mental Health and Reproductive Psychopharmacology

• Psychopharmacology of the reproductive life cycle
• Premenstrual symptoms and psychiatric medication considerations
• Psychotropic medication use during pregnancy
• Lactation and nursing considerations
• Postpartum psychiatric disorders
• Menopause-related psychiatric and medication considerations
• Women’s mental health treatment updates and clinical risk-benefit planning

Child, Adolescent and Geriatric Psychopharmacology

• Psychopharmacologic approaches in childhood affective disorders
• Basic neurobiological and pharmacological factors in child and adolescent treatment
• Depression and bipolar disorder in childhood and adolescence
• Latest advances in geriatric psychopharmacology
• Psychopharmacology in geriatrics and neuropsychiatry
• Age-specific medication risks, benefits, and clinical considerations
• Treatment problems and practical strategies in older populations

Sleep, Substance Use and Neuropsychiatric Disorders

• Neurobiology and treatment of sleep in psychiatric disorders
• Effective treatment of substance use disorders
• Alcohol, cannabis, opiates, and other substance-related disorders
• Psychopharmacology in patients with comorbid psychiatric and substance use disorders
• Clinical treatment strategies for complex dual-diagnosis patients
• Neurobiology and pharmacology of addiction-related disorders

AI, Digital Phenotyping and Autism Spectrum Disorders

• Digital phenotyping in psychiatry and psychopharmacology
• Role of artificial intelligence in psychiatric care and clinical decision-making
• Emerging technologies in psychiatric assessment and monitoring
• Latest advances in diagnosis and pharmacological treatment of autism spectrum disorders
• Practical implications of new research for modern psychiatric practice
• Future directions in psychopharmacology and mental health treatment

This course is best suited for psychiatrists, physicians, pharmacists, nurse practitioners, physician assistants, psychologists, social workers, residents, fellows, medical students, and trainees involved in mental health care and psychiatric medication management.

Topics include neurobiology, schizophrenia, bipolar disorder, depression, treatment-resistant depression, ketamine, ECT, TMS, psychedelics, anxiety disorders, PTSD, women’s mental health, sleep disorders, substance use disorders, child and adolescent psychopharmacology, geriatric psychopharmacology, neuropsychiatry, autism spectrum disorders, digital phenotyping, and AI in psychiatry.

Yes. The course focuses on practical psychopharmacology strategies for difficult-to-treat psychiatric patients, treatment-resistant conditions, medication selection, augmentation, and real-world clinical decision-making.

No. CME points and certificates are not included with this course.

Yes. This product is provided as recorded course access so you can review the material at your own pace.

You can contact support at support@getmedicalcourses.com.